Q4 2016 13F Holders as of 12/31/2016
-
Type / Class
-
Equity / Common Stock, par value $0.0001 per share
-
Shares outstanding
-
126M
-
Number of holders
-
85
-
Total 13F shares, excl. options
-
25.5M
-
Shares change
-
+2.26M
-
Total reported value, excl. options
-
$239M
-
Value change
-
+$21.2M
-
Put/Call ratio
-
0
-
Number of buys
-
48
-
Number of sells
-
-22
-
Price
-
$9.40
Significant Holders of Karyopharm Therapeutics Inc. - Common Stock, par value $0.0001 per share (KPTI) as of Q4 2016
93 filings reported holding KPTI - Karyopharm Therapeutics Inc. - Common Stock, par value $0.0001 per share as of Q4 2016.
Karyopharm Therapeutics Inc. - Common Stock, par value $0.0001 per share (KPTI) has 85 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 25.5M shares
of 126M outstanding shares and own 20.14% of the company stock.
Largest 10 shareholders include WELLINGTON MANAGEMENT GROUP LLP (5.73M shares), FMR LLC (4.73M shares), FRANKLIN RESOURCES INC (3.23M shares), Palo Alto Investors, LLC (3.2M shares), BlackRock Fund Advisors (1.38M shares), VANGUARD GROUP INC (1.13M shares), MILLENNIUM MANAGEMENT LLC (711K shares), BlackRock Institutional Trust Company, N.A. (556K shares), Tekla Capital Management LLC (500K shares), and JPMORGAN CHASE & CO (412K shares).
This table shows the top 85 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.